1. Home
  2. |Insights
  3. |SMi - Generics, Supergenerics and Patent Strategies

SMi - Generics, Supergenerics and Patent Strategies

Event | 05.14.12 - 05.15.12, 12:00 AM UTC - 12:00 AM UTC

The pharmaceutical generics industry is a fast moving and consistently expanding one. With the much referenced patent cliff rapidly approaching for many and already passed for some all businesses are looking to generics for a source of additional revenue.


SMi's conference will provide an excellent overview of the industry at the moment. Attendees will hear case studies from the big players in the market showing how they have handled issues and how they see the industry moving forward. They will also be covering some of the current regulatory issues and also the big Parma perspective of their movements in the generic field.


Sean-Paul Brankin will speak on the topic, "Patent settlement agreements, a generic standpoint."


Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.